© 2022 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2022 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Drew Hillier is an associate with Axinn, Veltrop & Harkrider LLP in the Intellectual Property and Litigation Groups, where he focuses on patent and other complex litigation, especially matters involving the life sciences.
November 11, 2020
Intellectual property attorneys discuss the Supreme Court oral arguments over the Affordable Care Act (ACA) and implications for the Biologics Price Competition and Innovation Act (BPCIA).